We are live on ! Find out more
IMA

ImageneBio Inc
IMA

45 hedge funds and large institutions have $41.9M invested in ImageneBio Inc in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 20 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.05% less ownership

Funds ownership: 6.56% → 6.51% (-0.05%)

13% less funds holding

Funds holding: 52 → 45 (-7)

19% less capital invested

Capital invested by funds: $52M → $41.9M (-$10.1M)

65% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 20

70% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 10

Holders
45
Holders Change
-7
Holders Change %
-13.46%
% of All Funds
0.6%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
3
Increased
7
Reduced
20
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$3.62M
2
AC
Aldebaran Capital
Indiana
+$356K
3
BCM
BML Capital Management
Indiana
+$180K
4
XT
XTX Topco
Cayman Islands
+$63.1K
5
Squarepoint
Squarepoint
New York
+$48.6K

Top Sellers

Rank Fund Capital Flow
1
GS
Gilead Sciences
California
-$1.22M
2
PLC
Peapod Lane Capital
New York
-$304K
3
JP Morgan Chase
JP Morgan Chase
New York
-$223K
4
Millennium Management
Millennium Management
New York
-$187K
5
Barclays
Barclays
United Kingdom
-$186K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$6.42M – – –
BOCH
2
Blue Owl Capital Holdings
New York
$5.24M – – –
BI
3
BVF Inc
California
$5.13M – – –
BCM
4
BML Capital Management
Indiana
$4.75M +$180K +10,412 +3%
O
5
OrbiMed
New York
$4.53M – – –
DTC
6
Deep Track Capital
Connecticut
$3.22M +$3.62M +209,626 New
OFM
7
Omega Fund Management
Massachusetts
$2.88M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.77M -$1.79K -104 -0.1%
GS
9
Gilead Sciences
California
$1.48M -$1.22M -70,767 -42%
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$1.02M – – –
NMC
11
NEA Management Company
Maryland
$768K – – –
SI
12
Sofinnova Investments
California
$490K – – –
BlackRock
13
BlackRock
New York
$446K -$5.04K -292 -1%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$406K -$15.6K -906 -3%
PLC
15
Peapod Lane Capital
New York
$379K -$304K -17,619 -42%
Renaissance Technologies
16
Renaissance Technologies
New York
$377K -$51.3K -2,976 -11%
AC
17
Aldebaran Capital
Indiana
$317K +$356K +20,650 New
Jacobs Levy Equity Management
18
Jacobs Levy Equity Management
New Jersey
$314K -$118K -6,827 -25%
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
$266K -$113K -6,567 -27%
BCM
20
Bridgeway Capital Management
Texas
$196K -$724 -42 -0.3%
Two Sigma Advisers
21
Two Sigma Advisers
New York
$194K -$8.62K -500 -4%
UBS Group
22
UBS Group
Switzerland
$129K +$41.4K +2,400 +40%
State Street
23
State Street
Massachusetts
$118K – – –
DCM
24
Deuterium Capital Management
Florida
$103K – – –
Citadel Advisors
25
Citadel Advisors
Florida
$102K -$966 -56 -0.8%
1
2 3

IMA Hedge Fund Activity: Q1 2025 in Review

45 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q1 2025, worth a combined $41.9M — down 19% from $52M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of IMA and 3 opened new positions — a net loss of 7 holders — while 20 trimmed existing stakes and 7 added.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $3.62M. The largest seller was Gilead Sciences, cutting an estimated $1.22M.

  • 45 institutional investors held ImageneBio Inc (IMA) as of Q1 2025, down from 52 in Q4 2024.
  • Funds reported $41.9M of ImageneBio Inc stock for Q1 2025, down 19% quarter-over-quarter.
  • 3 funds opened new ImageneBio Inc positions in Q1 2025 and 10 closed out, a net change of -7 holders.
  • The largest ImageneBio Inc buyer in Q1 2025 was Deep Track Capital, an estimated $3.62M added.
  • The largest ImageneBio Inc seller in Q1 2025 was Gilead Sciences, an estimated $1.22M sold.

Based on aggregated 13F filings for Q1 2025.